Abstract
Chikungunya virus is a reemerging human pathogen that causes debilitating arthritic disease in humans. Like dengue and Zika virus, CHIKV is transmitted by Aedes mosquitoes in an epidemic urban cycle, and is now rapidly spreading through the Americas since its introduction in the Caribbean in late 2013. There are no licensed vaccines or antiviral drugs available, and only a few vaccine candidates have passed Phase I human clinical trials. Using recombinant baculovirus expression technology, we have generated CHIKV glycoprotein subunit and virus-like particle (VLP) vaccines that are amenable to large scale production in insect cells. These vaccines, in particular the VLPs, have shown high immunogenicity and protection against CHIKV infection in different animal models of CHIKV-induced disease. Here, we describe the production, purification, and characterization of these potent CHIKV vaccine candidates.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Powers A, Logue C (2007) Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88:2363–2377
Enserink M (2007) Epidemiology. Tropical disease follows mosquitoes to Europe. Science 317:1485–1487
Gould E, Gallian P, De Lamballerie X, Charrel R (2010) First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin Microbiol Infect 16:1702–1704
Enserink M (2014) Infectious diseases. Crippling virus set to conquer Western Hemisphere. Science 344:678–679
Guzman M, Harris E (2014) Dengue. Lancet 385:453–465
Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L et al (2008) Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis 47:469–475
Suhrbier A, Jaffar-Bandjee M, Gasque P (2012) Arthritogenic alphaviruses—an overview. Nat Rev Rheumatol 8:42–429
Strauss J, Strauss E (1994) The alphaviruses: gene expression, replication, and evolution. Microbiol Mol Biol Rev 58:491–562
Levitt N, Ramsburg H, Hasty S, Repik P, Cole F et al (1986) Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine 4:157–162
Mallilankaraman K, Shedlock D, Bao H, Kawalekar O, Fagone P et al (2011) A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. PLoS Negl Trop Dis 5:e928
Muthumani K, Lankaraman K, Laddy D, Sundaram S, Chung C et al (2008) Immunogenicity of novel consensus-based DNA vaccines against chikungunya virus. Vaccine 26:5128–5134
Wang D, Suhrbier A, Penn-Nicholson A, Woraratanadharm J, Gardner J et al (2011) A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. Vaccine 29:2803–2809
Wang E, Volkova E, Adams A, Forrester N, Xiao S et al (2008) Chimeric alphavirus vaccine candidates for chikungunya. Vaccine 26:5030–5039
Akahata W, Yang ZY, Andersen H, Sun S, Holdaway H et al (2010) A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 16:334–338
Metz S, Gardner I, Geertsema C, Thuy L, Goh L et al (2013) Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl Trop Dis 7(3):e2124
Metz S, Martina B, van den Doel P, Geertsema C, Osterhaus A et al (2013) Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits. Vaccine 31:6092–6096
van Oers MM, Pijlman GP, Vlak JM (2015) Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology. J Gen Virol 96:6–23
Metz S, Pijlman G (2011) Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system. J Invertebr Pathol 107(Suppl):S16–S30
Pijlman G (2015) Enveloped virus-like particles as vaccines against pathogenic arboviruses. Biotechnol J 10:1–12
Metz S, Geertsema C, Martina B, Andrade P, Heldens J et al (2011) Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells. Virol J 8:353–361
Hopkins R, Esposito D (2009) A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line. Biotechniques 47:785–788
Kaba S, Salcedo A, Wafula P, Vlak J, van Oers M (2004) Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins. J Virol Methods 122:113–118
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Metz, S.W., Pijlman, G.P. (2016). Production of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect Cells. In: Chu, J., Ang, S. (eds) Chikungunya Virus. Methods in Molecular Biology, vol 1426. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3618-2_27
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3618-2_27
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3616-8
Online ISBN: 978-1-4939-3618-2
eBook Packages: Springer Protocols